Illumina’s NovaSeq Platform, the $100 Human Genome & Moore’s Law: is it Good Business?

At the JP Morgan Conference on Monday, Illumina took the opportunity showcase its new DNA sequencers, the NovaSeq 5000 and NovaSeq 6000, promising that by the end of the year

Share
Following the Quintiles IMS Megamerger, which CRO will Enter the Healthcare Analytics Space Next?

Earlier this year a megamerger between Quintiles, the world’s largest CRO, and healthcare data and consultancy firm IMS was announced, with the combined company branded as Quintiles IMS. With a

Share
Danaher Corporation Strengthens Diagnostics Offerings with $4B Acquisition of Cepheid

Danaher Corporation has announced the acquisition of medical diagnostics company Cepheid, strengthening their presence in the Molecular Diagnostics market. Danaher will pay $53 per share in cash, a premium of

Share
2016 US Venture Capital Investment into Life Sciences Companies: An Analysis by Evolution Bioscience

In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the Top 25 US Venture

Share
M&A Analysis: Bio-Techne enters Genomics market with $250M acquisition of Advanced Cell Diagnostics

Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to $75M. The acquisition marks

Share